Peptide record

TPDB41307

Anticancer standard
321 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41307
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 321-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
HGDNNSKPKPGGNSGNRGNNGDGASAKVGEITITPDNSKPGRYISSNPEYSLLAKLIDAESIKGTEVYTFHTRKGQYVKVTVPDSNIDKMRVDYVNWKGPKYNNKLVKRFVSQFLLFRKEEKEKNEKEALLKASELVSGMGDKLGEYLGVKYKNVAKEVANDIKNFHGRNIRSYNEAMASLNKVLANPKMKVNKSDKDAIVNAWKQVNAKDMANKIGNLGKAFKVADLAIKVEKIREKSIEGYNTGNWGPLLLEVESWIIGGVVAGVAISLFGAVLSFLPISGLAVTALGVIGIMTISYLSSFIDANRVSNINNIISSVIR
Physicochemical Analysis
C1567H2528N434O466S6
C
K
35096.30
10.03
50
32
131
+15
72.60
-0.318
92.31
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
38390
109.38
80
Residue Composition
number
24
A
11
R
31
N
14
D
0
C
18
E
3
Q
29
G
3
H
25
I
24
L
36
K
6
M
9
F
10
P
26
S
9
T
4
W
11
Y
28
V
Amino Acid Distribution
A: 24 R: 11 N: 31 D: 14 C: 0 E: 18 Q: 3 G: 29 H: 3 I: 25 L: 24 K: 36 M: 6 F: 9 P: 10 S: 26 T: 9 W: 4 Y: 11 V: 28
Chemical Descriptors
321
C1567H2528N434O466S6
35096.30
10.03
+15
72.60
-0.318
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

CancerPPD 2.0

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.